IndraLab

Statements



reach
"HCQ may reduce the odds of CHB occurrence in fetuses exposed to maternal anti-Ro and SSA antibodies, especially in mothers who already had a child with CHB."

reach
"Conclusions:. These prospective data support that HCQ significantly reduces the recurrence of CHB below the historical rate by more than 50%, suggesting that this drug be prescribed for secondary prevention of fetal cardiac disease in anti-SSA/Ro-exposed pregnancies."

reach
"The next open-label multicenter trial [32] supported that HCQ significantly reduces CHB recurrence below the historical rate by >50%, suggesting that this drug should be prescribed for the secondary prevention of fetal cardiac disease in antiSSA/Ro-exposed pregnancies."

reach
"Thus, given biologic plausibility and observational data, a Phase II study was initiated to address whether HCQ reduces the recurrence of CHB below the historical rate of 18% (14)."

reach
"In conclusion, data from this prospective single-arm clinical trial support that HCQ reduces the recurrence of CHB in anti-SSA/Ro exposed pregnancies by more than half and should be considered for secondary prevention."

reach
"It has been proposed that maternal hydroxychloroquine treatment can prevent CHB and may provide a molecular basis for such a potential protective effect [32]."

reach
"These results suggest that hydroxychloroquine be prescribed to prevent the recurrence of CHB."
| PMC

reach
"It is recommended that HCQ treatment should be started between the 6th and 10th gestational weeks at a dose of 400 mg orally once a day [13,84], and an early treatment with HCQ decreases the recurrence of CHB by >50% [66]."

reach
"Izmirly et al. in a retrospective study firstly highlighted that HCQ significantly decreased the occurrence of CHB in patients having a previous affected child."

reach
"In this paper, they saw that HCQ significantly reduced the recurrence of CHB by >50%."

reach
"This case illustrates that HCQ does not invariably prevent CHB and is consistent with the clinical observation that this approach will not be effective in all anti-SSA/Ro exposed foetuses."

reach
"Preventative therapy with hydroxychloroquine (HCQ) reduces the recurrence rate of CHB in subsequent pregnancies by ~50%."

reach
"It was reported that sustained use of hydroxychloroquine could significantly reduce the risk of CHB and neonatal lupus syndromes."

reach
"In the following cohort study, HCQ use lowered the recurrence rate of CHB by 60% [34]."

reach
"Hydroxychloroquine has been proposed to reduce neonatal morbidity and the recurrence risk of CHB XREF_BIBR in patients with SLE."

reach
"A retrospective review of several large databases suggests that hydroxychloroquine use during pregnancy may decrease the risk of CHB."

reach
"New clinical trials are in progress for the prevention of CHB by HCQ and/or IVIG [60] ."

reach
"HCQ may reduce the odds of CHB occurrence in fetuses exposed to maternal anti-Ro and SSA Ab, especially in mothers who have already had a child with congenital heart block [XREF_BIBR]."

reach
"HCQ significantly reduces the recurrence rate of CHB in women who previously delivered an affected infant, with a protective effect exceeding 50% [18,88]."

reach
"While a small observational study suggests that hydroxychloroquine may partially prevent CHB in connective tissue disease patients, conflicting evidence exists regarding effective treatment."